Tag: diabetes
Only 40% of diabetes patients get recommended kidney health testing, say...
Not enough diabetes patients are getting their recommended kidney health screenings, according to a new study by the US National Kidney Foundation (NKF) and...
Finerenone to be trialled for CKD in type 1 diabetes patients
Bayer has announced the initiation of FINE-ONE, a global, multicentre, randomised, placebo-controlled, double-blind, parallel-group Phase III study to evaluate the efficacy and safety of...
Renalytix announces publication of real-world evidence on KidneyIntelX risk assessment test
Renalytix has announced the release of new real-world evidence case studies published in the peer reviewed journal Diabetic Nephropathy entitled: “The Need for Risk...
Blood pressure drug could inhibit diabetic kidney disease
A new way to reduce progression of diabetic kidney disease, affecting 40% of people with diabetes, has been discovered by researchers. A University of...
KDIGO guideline for diabetic CKD patient treatment updated
The Kidney Disease: Improving Global Outcomes (KDIGO) Work Group has issued a 2022 update to its 2020 guideline for the management of diabetes in...
NHS Scotland treatment of CKD with finerenone accepted by SMC
Bayer has announced that Kerendia (finerenone, 10mg and 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) antagonist, has been accepted for use within...
Journey Biosciences announces company launch, introduces NaviDKD screening technology for diabetes-related...
Journey Biosciences—a biotechnology company with a proactive diagnostic screening technology for high-risk kidney complications associated with diabetes, has announced its company launch, and the...
Pilot study of third COVID-19 vaccine dose in kidney transplant recipients...
A pilot study has begun to assess the antibody response to a third dose of an authorised COVID-19 mRNA vaccine in kidney transplant recipients...